46 research outputs found
Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease
<p>Abstract</p> <p>Background</p> <p>Inflammatory bowel disease (IBD) is used to describe a state of idiopathic, chronic inflammation of the gastrointestinal tract. The two main phenotypes of IBD are Crohn's disease (CD) and ulcerative colitis (UC). The major cause of IBD-associated mortality is colorectal cancer. Although both host-genetic and exogenous factors have been found to be involved, the aetiology of IBD is still not well understood. In this study we characterized thirteen <it>Escherichia coli </it>strains from patients with IBD by comparative genomic hybridization employing a microarray based on 31 sequenced <it>E. coli </it>genomes from a wide range of commensal and pathogenic isolates.</p> <p>Results</p> <p>The IBD isolates, obtained from patients with UC and CD, displayed remarkably heterogeneous genomic profiles with little or no evidence of group-specific determinants. No IBD-specific genes were evident when compared with the prototypic CD isolate, LF82, suggesting that the IBD-inducing effect of the strains is multifactorial. Several of the IBD isolates carried a number of extraintestinal pathogenic <it>E. coli </it>(ExPEC)-related virulence determinants such as the <it>pap</it>, <it>sfa</it>, <it>cdt </it>and <it>hly </it>genes. The isolates were also found to carry genes of ExPEC-associated genomic islands.</p> <p>Conclusions</p> <p>Combined, these data suggest that <it>E. coli </it>isolates obtained from UC and CD patients represents a heterogeneous population of strains, with genomic profiles that are indistinguishable to those of ExPEC isolates. Our findings indicate that IBD-induction from <it>E. coli </it>strains is multifactorial and that a range of gene products may be involved in triggering the disease.</p
Breast cancer incidence after the start of mammography screening in Denmark
Mammography screening may lead to overdiagnosis of asymptomatic breast cancers, that would otherwise not have given rise to clinical symptoms. This aspect was studied in three regional screening programmes in Denmark, which started in Copenhagen municipality, Fyn county, and Frederiksberg municipality in 1991, 1993, and 1994, respectively. In these regions, we compared time trends in incidence of invasive breast cancer with the rest of Denmark. Since the number of clinical mammograms was relatively low, it was reasonable to assume that the breast cancer incidence outside the three screening regions represented the incidence of a population with low-intensity opportunistic screening. In Copenhagen and Fyn, a prevalence peak in incidence was seen during the first invitation round. During the subsequent invitation rounds, the incidence dropped to a level in line with the incidence expected without screening. The pattern was different in the small municipality of Frederiksberg, where the sensitivity was low during the first invitation round. Inclusion of screen-detected ductal carcinoma in situ cases did not change these results. The experiences from Copenhagen and Fyn show that organised mammography screening can operate without overdiagnosis of breast cancer
Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme
<p>Abstract</p> <p>Background</p> <p>The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme.</p> <p>Methods</p> <p>The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring.</p> <p>Results</p> <p>Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines.</p> <p>Conclusions</p> <p>Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.</p
Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units
RLH, TBS and ALF made substantial contributions to the conception and
design of the article, the acquisition, analysis and interpretation of the data,
and drafting of the article. ECM, JSCM and NB made substantial
contributions to the conception and design of the study.Background: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer deaths
among women worldwide. The use of mobile mammography units to offer screening to women living in remote
areas is a rational strategy to increase the number of women examined. This study aimed to evaluate results from
the first 2 years of a government-organized mammography screening program implemented with a mobile unit
(MU) and a fixed unit (FU) in a rural county in Brazil. The program offered breast cancer screening to women living
in Barretos and the surrounding area.
Methods: Based on epidemiologic data, 54 238 women, aged 40 to 69 years, were eligible for breast cancer
screening. The study included women examined from April 1, 2003 to March 31, 2005. The chi-square test and
Bonferroni correction analyses were used to evaluate the frequencies of tumors and the importance of clinical
parameters and tumor characteristics. Significance was set at p < 0.05.
Results: Overall, 17 964 women underwent mammography. This represented 33.1% of eligible women in the area.
A mean of 18.6 and 26.3 women per day were examined in the FU and MU, respectively. Seventy six patients were
diagnosed with breast cancer (41 (54%) in the MU). This represented 4.2 cases of breast cancer per 1000
examinations. The number of cancers detected was significantly higher in women aged 60 to 69 years than in
those aged 50 to 59 years (p < 0.001) or 40 to 49 years (p < 0.001). No difference was observed between women
aged 40 to 49 years and those aged 50 to 59 years (p = 0.164). The proportion of tumors in the early (EC 0 and EC
I) and advanced (CS III and CS IV) stages of development were 43.4% and 15.8%, respectively.
Conclusions: Preliminary results indicate that this mammography screening program is feasible for implementation
in a rural Brazilian territory and favor program continuation
Use of hyperlinks in electronic test result communication: a survey study in general practice
A Novel Protein Kinase-Like Domain in a Selenoprotein, Widespread in the Tree of Life
Selenoproteins serve important functions in many organisms, usually providing essential oxidoreductase enzymatic activity, often for defense against toxic xenobiotic substances. Most eukaryotic genomes possess a small number of these proteins, usually not more than 20. Selenoproteins belong to various structural classes, often related to oxidoreductase function, yet a few of them are completely uncharacterised